AdvanCell Isotopes is involved in the production and supply of Alpha Emitting Isotopes for Targeted Alpha Therapy for cancer. Targeted Alpha Therapy is a revolutionary treatment that uses alpha-emitting isotopes attached to molecules that deliver cytotoxic radiation direct to tumours, i.e. radiotherapy at the molecular level. AdvanCell’s goal is a safe and effective treatment for patients with multiple forms of cancer, that will become a standard of care.